Le Lézard
Classified in: Health
Subjects: CCA, TRD, FVT

Varian U.S. Tariff Exclusion Request Granted for Radiotherapy System Components


PALO ALTO, Calif., Sept. 23, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the United States Trade Representative (USTR) has granted exclusion of components sourced from China for linear accelerators manufactured in the U.S from Section 301 tariffs. The exemption became effective on September 20, 2019.

"We are thankful for the USTR and U.S. government's continued recognition of the positive impact of Varian treatment technology in the fight against cancer by granting a tariff exclusion to these components," said Dow Wilson, president and chief executive officer, Varian. "The supply of components without disruption plays an important role in our system manufacturing process so we can continue delivering cancer fighting technology and honor our commitment to creating a world without fear of cancer."

Varian is in its quiet period but will evaluate if further comments are necessary after completing its assessment of the impact of this exclusion.  The company's fiscal year 2019 earnings conference call is scheduled for Wednesday, October 23, 2019 at 1:30pm Pacific Time.

About Varian
At Varian, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 9,200 employees across 70 countries keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Press Contact
Mark Plungy
Director, Global Public Relations
+1 (650) 424-5630
[email protected]

Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
[email protected]

SOURCE Varian


These press releases may also interest you

at 14:04
Hebrew SeniorLife's Jack Satter House held ceremonies on June 10th to announce the receipt of an up to $20 million grant to its Revere supportive housing community to provide efficiency and climate resilience improvements. The U.S....

at 14:00
"I wanted to create a simple way to keep the chin elevated and the mouth closed while sleeping to help prevent snoring," said an inventor, from Brentwood, Tenn., "so I invented the SHUT IT UP. My design would eliminate the need to use uncomfortable...

at 14:00
Luxor Scientific, a leader in scientific research, announces groundbreaking advancements in combatting the rise of deadly illicit drugs. Leveraging expertise in toxicology, Luxor has developed advanced testing solutions to address the nation's...

at 13:57
The Ismael Cala Foundation and the Acevedo Foundation announced a strategic alliance that will allow them to multiply their impact and reach more than a thousand vulnerable young people and adolescents, initially in the state of Florida. This...

at 13:50
Ernst & Young LLP (EY US) today announced that Michael Kopko, CEO and co-Founder of Pearl Health, was named an Entrepreneur Of The Year® 2024 New York Award winner. Entrepreneur Of The Year is the preeminent competitive awards program for...

at 13:48
Alera Health proudly presented the first-ever G.R.I.T Award at the 2024 ONEcare Symposium on June 18th, honoring HOPE Inc. for their outstanding tenacity and perseverance in improving health outcomes. The G.R.I.T. Award, which stands for "Grit,...



News published on and distributed by: